TICKERNERD
Menu
XWELXWELHealthcare · Diagnostics & Research

XWEL Stock Forecast: XWELL, Inc. Price Predictions for 2026-2027

Last close, 14 Oct 2026
$0.73
−7.59% on the day

Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 35 of 100 as at 14 Oct 2026 — in the lower half.

Market cap
$7.9M
Ticker Nerd rank
35 / 100
Median analyst target
—
Analysts covering
0
Revenue$7.1M−7.1% y/y
Operating income−$1.9M
Net income−$1.9M
Free cash flow−$4.7M
Quarterly, 8 quarters to 30 June 2026 · latest quarter's figure shown
Total return, dividends reinvested
1W
−18.9%
1M
−21.5%
YTD
+58.7%
1Y
−31.8%
From 52W high
−57.1%
From 52W low
+151.7%
$0.29
$1.70
52-week range, adjusted closes · the dot is the last close
Ticker Nerd rank

XWEL stock analysis: one number for the whole business

Consensus tells you what everyone already believes. The model scores XWELL, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.

Where the model ranks itAs at 14 Oct 2026
35 / 100

Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested

Accruals
95
Size
93
Issuance
64
Growth
54
Momentum
28
Revisions
25
Quality
23
Value
13
Volatility
8

Accruals (95): Reported profit is backed by cash, and the company is not expanding recklessly.

Volatility (8): The share price moves around a lot.

Built and run by Aslam Ghouse, an ex-Goldman Sachs quant trader with fourteen years in markets.

Wall Street

XWEL stock forecast 2026-2027: analyst price targets & predictions

The bullish and bearish analyst opinions on XWEL, reported as data — targets and ratings, the market's view beside the model's.

Share price and the analyst range, 12 monthsAdjusted close, US dollars
$0.20$0.40$0.60$0.80$1.00$1.20$1.40$1.60Jan 26Apr 26Jul 26Oct 26XWEL

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Data provided by Twelve Data

Recent analyst actionsNewest first

Of the 9 most recent actions, 1 moved their price target up and 2 moved it down.

DateFirmActionRatingTarget
17 Nov 2023HC Wainwright & Co.MaintainsBuy$1.00 → $7.00
25 Aug 2023HC Wainwright & Co.ReiteratesBuy$1.00
16 May 2023HC Wainwright & Co.ReiteratesBuy$1.00
18 Apr 2023HC Wainwright & Co.ReiteratesBuy$1.00
4 Apr 2023HC Wainwright & Co.MaintainsBuy$1.50 → $1.00
16 Nov 2022HC Wainwright & Co.MaintainsBuy$2.00 → $1.50
18 May 2022HC Wainwright & Co.MaintainsBuy—
17 Nov 2021HC Wainwright & Co.MaintainsBuy—
16 Feb 2021HC Wainwright & Co.InitiatesBuy—

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Market Radar

This page is one stock. Monday covers all of them.

Computed off the Friday close and sent before the US open.

Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. XWEL appears on the weeks it earns a place.

Free, every Monday. Unsubscribe any time.

Performance

XWEL vs the S&P 500

Both lines are total return — dividends reinvested — so the comparison is honest on both sides.

Over the twelve months to 14 Oct 2026, XWELL, Inc. returned −31.8% against +17.5% for the S&P 500, dividends included.

XWEL vs S&P 500, last 12 monthsTotal return, rebased to 100
20406080100120140Jan 26Apr 26Jul 26Oct 26XWELS&P 500

Download this chart as an image — free to reuse; link this page as the source.

Data provided by Twelve Data

Estimates

XWEL analyst estimate revisions

Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.

Fundamentals

XWELL, Inc. (XWEL) financial data

A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.

Valuation
Trailing P/E
−0.2×

Cheaper than 78% of US stocks

Price / sales
0.3×

Cheaper than 89% of US stocks

Price / book
0.8×

Cheaper than 76% of US stocks

EV / EBITDA
−1.3×

Cheaper than 70% of US stocks

Growth & margins
Revenue growth (YoY)
−7.1%

Higher than 18% of US stocks

Earnings growth (YoY)
−7.1%

Higher than 29% of US stocks

Gross margin
41.3%

Higher than 51% of US stocks

Operating margin
−26.1%

Higher than 20% of US stocks

Net margin
−82.9%

Higher than 7% of US stocks

Returns & dividend
Return on equity
−361.4%

Higher than 4% of US stocks

Return on assets
−31.4%

Higher than 13% of US stocks

Dividend yield
0.0%

Higher than 1% of US dividend payers

Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.

Key statistics

XWELL, Inc. (XWEL) statistics: revenue, profit & scale

The headline figures, each with its date. Every row carries its own link — cite it straight from here.

  • XWELL, Inc. has a market value of $7.9M and an enterprise value of $12.4M.

  • Revenue in the twelve months to 30 June 2026: $28.3M. The latest quarter shrank 7.1% year on year.

  • Net income over the same four quarters: −$22.4M, a −79.1% net margin.

  • Free cash flow in the twelve months to 30 June 2026: −$13.5M.

  • XWELL, Inc. spent $10.8M on share buybacks in the twelve months to 30 June 2026.

  • Shares outstanding: 8.5M.

  • Trailing P/E: −0.2×; forward P/E: −0.3× — the forward figure prices analyst consensus estimates, not reported earnings.

  • Forward dividend yield: 0.00%, paying out 0% of earnings.

  • XWELL, Inc. employs 175 people — $162K of revenue per employee.

Statement figures: company filings via Twelve Data, four quarters to 30 June 2026 · market figures as at 14 Oct 2026

Data provided by Twelve Data

Peers

XWEL vs competitors

The nearest names by industry and size, scored by the same model — like for like.

Its peer group, ranked by the same modelDiagnostics & Research
CompanyMarket capTKN rank
XWELXWELL, Inc.$7.9M
35
NDRAENDRA Life Sciences, Inc.$7.2M
27
ADVBAdvanced Biomed, Inc.$8.5M
23
BIAFbioAffinity Technologies, Inc.$4.6M
16
ISPCiSpecimen, Inc.$2.6M
23
PRPOPrecipio, Inc.$39.0M
47
MDXHMDxHealth SA$60.3M
52

Look up any of the roughly 4,600 stocks we score.

The rank is the raw material. Whether the rules would actually own XWELL, Inc. — and when they’d sell — is the membership. See the Ticker Nerd 20 →

News

Latest XWEL news & analysis

XWELL Appoints Global Energy and Capital Markets Leader Gerard Reid to its Board of Directors

GlobeNewsWire · 5 Aug 2026neutral

XWELL, Inc. announced the appointment of Gerard Reid to its Board of Directors, effective immediately. Separately, Ezra Ernst resigned as a director to focus on his responsibilities as the company's President and Chief Executive Officer.

Why it matters — XWELL watchers would care because the board's composition is changing, with a new director joining and the CEO stepping off the board to focus on his executive role.

FAQ

Frequently asked questions about XWEL stock

How does Ticker Nerd's model rank XWEL?

As at 14 Oct 2026, XWELL, Inc. ranks 35 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Accruals (95 of 100).

What is the XWEL stock forecast for 2030?

No analyst covering XWELL, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for XWEL are extrapolating price history, which says nothing about the business.

How has XWEL stock performed over the past year?

XWELL, Inc. returned -31.8% over the 12 months to 14 Oct 2026, with dividends reinvested. Past performance does not indicate future returns.

What does XWELL, Inc. do?

XWELL Inc. is a health and wellness services company focused on travelers and people on the move.

What is the latest news on XWEL?

The most recent item we track (GlobeNewsWire, 5 Aug 2026): "XWELL Appoints Global Energy and Capital Markets Leader Gerard Reid to its Board of Directors". XWELL, Inc. announced the appointment of Gerard Reid to its Board of Directors, effective immediately. Separately, Ezra Ernst resigned as a director to focus on his responsibilities as the company's President and Chief Executive Officer.

Company

About XWELL, Inc.

XWELL Inc. is a health and wellness services company focused on travelers and people on the move. The company operates through multiple business segments that serve airport and travel environments, including spa services, wellness testing, and body care offerings. Its services include massage, nail and skin care, diagnostic testing, airport-based wellness centers, and face and body waxing, supported by related wellness and travel products. XWELL also extends its reach through digital and online channels, combining in-person service locations with ancillary products and support services. By concentrating on high-traffic locations such as airports and other travel settings, XWELL occupies a niche position in the consumer services market, addressing convenience-oriented wellness needs across the travel experience.

CEO Mr. Ezra T. Ernst · 175 employees · United States · https://www.xwell.com